New drug combo shows promise for controlling advanced breast cancer
NCT ID NCT02668666
First seen Jan 27, 2026 · Last updated May 18, 2026 · Updated 12 times
Summary
This study tested a combination of two drugs, palbociclib and tamoxifen, as a first treatment for women with a certain type of advanced breast cancer (HR+/HER2-). The goal was to see how long the cancer could be kept from growing. 49 women took part, and the study measured how long they lived without the cancer getting worse.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Michigan State University
Lansing, Michigan, 48910, United States
-
Penn State Cancer Institute
Hershey, Pennsylvania, 17033, United States
-
ProHealth Care
Waukesha, Wisconsin, 53188, United States
-
University of Illinois Cancer Center
Chicago, Illinois, 60612, United States
-
University of Minnesota
Minneapolis, Minnesota, 55455, United States
-
University of Nebraska Medical Center
Omaha, Nebraska, 68198, United States
-
University of Wisconsin
Madison, Wisconsin, 53705, United States
Conditions
Explore the condition pages connected to this study.